Concluding Remarks: Experience with the European Community's Multi-State and Concertation Procedures

Abstract

The multi-state and concertation procedures have generally been successful, but there is room for improvement. Pharmaceutical companies, regulatory agencies, and the European Commission must work together to truly achieve a single European pharmaceutical market. These remarks discuss actions which could be introduced to facilitate the transition from the old regulatory system to the new.